TGA Latest report.Reporting rates of myocarditis and...

First 94162 Last

Share
Profile

Follow
Bananabender1

11,621 Posts.

10

05/04/24

22:24

Post #: 73215594
Share

Originally posted by Bananabender1: ↑

Myocarditis and pericarditisThere is a link between COVID-19 vaccines and rare side effects of myocarditis and pericarditis.Myocarditis is inflammation of the heart muscle.Pericarditis is inflammation of the pericardium (the thin, sac-like tissue surrounding the heart muscle).Myocarditis and pericarditis can occur together or separately. Myocarditis and pericarditis occur in the general population from a variety of causes. Not all cases that occur after vaccination are caused by the vaccine. Myocarditis and pericarditis can also be caused by COVID-19.The risk of myocarditis is highest in people aged 16 to 30 years (peak 16 to 18 years), and is higher in males than females.1-3 The risk does not appear to be as high with booster doses compared with dose 2 of the primary course.3,4Up-to-date information on cases and rates reported to the Therapeutic Goods Administration (TGA) is available in its COVID-19 vaccine safety reports. The risk of myocarditis is higher (although still rare) after vaccination with Moderna original formulation compared with Pfizer original formulation. It is estimated there are around 2 more cases per 100,000 second vaccine doses in people under 40 who received Moderna original formulation than Pfizer original formulation.Evidence suggests that AstraZeneca and Novavax are probably associated with a small increased risk of myocarditis and pericarditis.This risk after AstraZeneca looked lower than the risk after Moderna original formulation or Pfizer original formulation. The small number of total doses of Novavax given globally prevents the calculation of a precise risk as of February 2023.ATAGI will continue to monitor data as it emerges and update advice accordingly.There is no evidence to suggest myocarditis or pericarditis is more severe following a particular brand of vaccine.

Expand

TGA Latest report.

Reporting rates of myocarditis and pericarditis (inflammation of the heart or membrane around the heart) following vaccination are very stable. We will continue to monitor and review these adverse effects and will communicate any updated safety advice if needed.Myocarditis is reported in around 1-2 in every 100,000 people who receive Comirnaty (Pfizer), around 2 in every 100,000 of those who receive Spikevax (Moderna) and around 4 in every 100,000 people who receive Nuvaxovid (Novavax). Detailed information about our analysis of myocarditis and pericarditis following vaccination with an mRNA vaccine or Nuvaxovid (Novavax) is available in a previous vaccine safety report.
Upvote

Reply